Evidence map›Paper›PMID 24558358›Full record

ArticlePloS one2014

Abnormal chondrocyte apoptosis in the cartilage growth plate is influenced by genetic background and deletion of CHOP in a targeted mouse model of pseudoachondroplasia.

Katarzyna A Piróg, Andreja Irman, Siobhan Young, Poonam Halai, Peter A Bell, Raymond P Boot-Handford, Michael D Briggs

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Genetic Disorders of the Extracellular Matrix.Anatomical record (Hoboken, N.J. : 2007) · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Antisense Reduction of Mutant COMP Reduces Growth Plate Chondrocyte Pathology.Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
  13. Emerging targets in osteoarthritis therapy.Current opinion in pharmacology · 2015
    Review
  14. Review
  15. Article
  16. Article
  17. Pseudoachondroplasia/COMP - translating from the bench to the bedside.Matrix biology : journal of the International Society for Matrix Biology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Katarzyna A PirógInstitute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom.
Andreja IrmanWellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, United Kingdom.
Siobhan YoungWellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, United Kingdom.
Poonam HalaiWellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, United Kingdom.
Peter A BellInstitute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom.
Raymond P Boot-HandfordWellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, United Kingdom.
Michael D BriggsInstitute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom.
Newcastle University · GBWellcome Centre for Cell-Matrix Research · GBUniversity of Manchester · GB

Funding

Wellcome Trust 071161/Z/03/ZWellcome Trust 084353
6 · The paper itself

Abstract

Pseudoachondroplasia (PSACH) is an autosomal dominant skeletal dysplasia caused by mutations in cartilage oligomeric matrix protein (COMP) and characterised by short limbed dwarfism and early onset osteoarthritis. Mouse models of PSACH show variable retention of mutant COMP in the ER of chondrocytes, however, in each case a different stress pathway is activated and the underlying disease mechanisms remain largely unknown. T585M COMP mutant mice are a model of moderate PSACH and demonstrate a mild ER stress response. Although mutant COMP is not retained in significant quantities within the ER of chondrocytes, both BiP and the pro-apoptotic ER stress-related transcription factor CHOP are mildly elevated, whilst bcl-2 levels are decreased, resulting in increased and spatially dysregulated chondrocyte apoptosis. To determine whether the abnormal chondrocyte apoptosis observed in the growth plate of mutant mice is CHOP-mediated, we bred T585M COMP mutant mice with CHOP-null mice to homozygosity, and analysed the resulting phenotype. Although abnormal apoptosis was alleviated in the resting zone following CHOP deletion, the mutant growth plates were generally more disorganised. Furthermore, the bone lengths of COMP mutant CHOP null mice were significantly shorter at 9 weeks of age when compared to the COMP mutant mice, including a significant difference in the skull length. Overall, these data demonstrate that CHOP-mediated apoptosis is an early event in the pathobiology of PSACH and suggest that the lack of CHOP, in conjunction with a COMP mutation, may lead to aggravation of the skeletal phenotype via a potentially synergistic effect on endochondral ossification.

Indexed as

ApoptosisAchondroplasiaAnimalsBone and BonesCartilageCell ProliferationChondrocytesDisease Models, AnimalGrowth PlateHomozygoteMiceMice, Inbred C57BLMice, KnockoutMice, Mutant StrainsMutationPhenotypeDdit3 protein, mouseTranscription Factor CHOP

Identifiers

PMID24558358
PMCPMC3928032
OpenAlexW2012266279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.